Versant Capital Management, Inc Amneal Pharmaceuticals, Inc. Transaction History

Versant Capital Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$3.01 - $4.46 $261 - $388	-87 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$2.65 - $5.56 $230 - $483	87 New	87 $0
Q2 2019 Jul 16, 2019	SELL	$6.44 - $14.29 $122 - $271	-19 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$11.87 - $14.84 $225 - $281	19 New	19 $0
Q1 2019 Apr 23, 2019	SELL	$11.87 - $14.84 $13,460 - $16,828	-1,134 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$16.4 - $24.27 $18,597 - $27,522	1,134 New	1,134 $25,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.36B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.